Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 1 AL 15

Massive Weight Loss From Rivastigmine Patch in an Older Patient: A Rare Case

Naharci MI, Veizi BGY, Katipoglu B, Akcan E, Yoruk F, Tasci I.

J Clin Psychopharmacol. 2022 Mar-Apr 01;42(2):222-224. doi: 10.1097/JCP.0000000000001254.

Findings of Sequential Pilot Trials of Aliviado Dementia Care to Inform an Embedded Pragmatic Clinical Trial

Lin SY, Schneider CE, Bristol AA, Clancy M, Sprague SA, Aldridge M, Cortes T, Goldfeld KS, Kutner JS, Mitchell SL, Shega JW, Wu B, Zhu CW, Brody AA.

Gerontologist. 2022 Feb 9;62(2):304-314. doi: 10.1093/geront/gnaa220.

Nutraceuticals and their Derived Nano-Formulations for the Prevention and Treatment of Alzheimer's Disease

Iqubal A, Iqubal MK, Fazal SA, Pottoo FH, Haque SE.

Curr Mol Pharmacol. 2022;15(1):23-50. doi: 10.2174/1874467214666210309115605.

Roles of Cannabidiol in the Treatment and Prevention of Alzheimer's Disease by Multi-target Actions

Zhang XB, Li J, Gu J, Zeng YQ.

Mini Rev Med Chem. 2022;22(1):43-51. doi: 10.2174/1389557521666210331162857.

Dietary Nutrients and Prevention of Alzheimer's Disease

Chauhan PS, Yadav D, Arukha AP.

CNS Neurol Disord Drug Targets. 2022;21(3):217-227. doi: 10.2174/1871527320666210405141123.

Alzheimer's disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?

Arrona Cardoza P, Spillane MB, Morales Marroquin E.

Nutr Rev. 2022 Jan 10;80(2):271-281. doi: 10.1093/nutrit/nuab022.

Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease

Kumar B, Thakur A, Dwivedi AR, Kumar R, Kumar V.

Curr Med Chem. 2022;29(10):1757-1803. doi: 10.2174/0929867328666210512005508.

Use of Zebrafish Genetic Models to Study Etiology of the Amyloid-Beta and Neurofibrillary Tangle Pathways in Alzheimer's Disease

Kiper K, Freeman JL.

Curr Neuropharmacol. 2022 Mar 4;20(3):524-539. doi: 10.2174/1570159X19666210524155944.

Recommendations for Preclinical Testing of Treatments Against Alzheimer's Disease-Related Epileptiform Spikes in Transgenic Rodent Models

Jin N, Babiloni C, Drinkenburg WH, Hajós M, Nygaard HB, Tanila H.

J Alzheimers Dis. 2022;88(3):849-865. doi: 10.3233/JAD-210209.

An Overview of β-Amyloid Cleaving Enzyme 1 (BACE1) in Alzheimer's Disease Therapy: Elucidating its Exosite-Binding Antibody and Allosteric Inhibitor

Ugbaja SC, Lawal MM, Kumalo HM.

Curr Med Chem. 2022;29(1):114-135. doi: 10.2174/0929867328666210608145357.

Quantitative Assessment of Cortical Excitability in Alzheimer's Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses

Joseph S, Patterson R, Wang W, Blumberger DM, Rajji TK, Kumar S.

J Alzheimers Dis. 2022;88(3):867-891. doi: 10.3233/JAD-210311.

Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease

Wang Y, Dykes GA.

CNS Neurol Disord Drug Targets. 2022;21(1):14-25. doi: 10.2174/1871527320666210806165751.

Alzheimer's Disease and β-secretase Inhibition: An Update with a Focus on Computer-aided Inhibitor Design

Ugbaja SC, Lawal IA, Kumalo HM, Lawal MM.

Curr Drug Targets. 2022;23(3):266-285. doi: 10.2174/1389450122666210809100050.

Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer's Disease: A Review

Ahmad SS, Younis K, Philippe J, Aschner M, Khan H.

CNS Neurol Disord Drug Targets. 2022;21(7):610-620. doi: 10.2174/1871527320666210811160007.

Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study

Holland N, Malpetti M, Rittman T, Mak EE, Passamonti L, Kaalund SS, Hezemans FH, Jones PS, Savulich G, Hong YT, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB.

Brain. 2022 Mar 29;145(1):340-348. doi: 10.1093/brain/awab282.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias